• Suspected tick exposure: history of tick bites or time spent in tick-endemic areas.
• Fever-like symptoms: unexplained temperature elevation after outdoor exposure.
• Flu-like presentation: malaise, headache or generalised discomfort.
• Myalgia: muscle pain following suspected exposure.
• Neurological concerns: meningitis-like symptoms during or after illness.
• Liver involvement: elevated liver enzymes or right-upper-quadrant discomfort.
• Kidney involvement: reduced urine output or related symptoms.
• Unexplained fatigue: persistent tiredness following outdoor exposure.
• Arthralgia: joint discomfort developing after suspected contact.
• Follow-up assessment: evaluating IgM or IgG patterns after previous exposure.

Overview

The Ehrlichia IgM and IgG Antibodies test measures serum antibodies directed against Ehrlichia and Anaplasma species, organisms that may be transmitted through tick exposure. IgM markers may indicate more recent contact, while IgG provides information relating to past exposure. This test complements cellular immune assessments such as EliSpot, offering insight into the humoral component of the immune response.

This panel may relate to concerns including fever-like illness, flu-like symptoms, myalgia, neurological signs resembling meningitis, liver or kidney involvement, arthralgia or persistent fatigue following outdoor activity in tick-endemic areas. It may also assist practitioners when exploring suspected tick exposure where timing or progression is unclear.

Practitioners typically interpret these findings alongside exposure history, symptom evolution, outdoor activity, previous laboratory assessments and information shared by clients. This supports a broader understanding of how antibody patterns may align with recent or past exposure.

Practical

Ehrlichia/Anaplasma-IgM/IgG-antibodies

Material: 1x10 ml Serum-Tube

This sample requires a blood draw